… anti-cancer agents. In view of its unique physic-chemical and biological properties, it has been
used as a privileged scaffold in the anti-cancer agents … promising anti-cancer agents used …

… an antitumor agent in anticancer treatment. The members of this privileged scaffold quinoline
… of quinoline and isoquinoline derivatives as antitumor agents and refine the path of these …

… In this regard the study of transition metal-based anticancer agents remains an area of
intense research activity [25]. The covalent modification of DNA is a classical strategy, as …

… In the past few decades, literature reports investigation of chromones as anticancer agents
against a variety of molecular targets namely, protein kinases, protein tyrosine phosphatases, …

… Currently, several anticancer agents are commercially available in the global market. … more
interest in developing newer novel potential anticancer agents. In the search for new drugs …

… privileged and promising scaffold in the field of medicinal chemistry along with its anticancer
… of new thiazolidinedione derivatives as anticancer agents. Furthermore, in the same search …

… Increasing interest in quinoline-based anticancer agents … agents. With these in mind,
quinoline will remain an essential structural motif in anticancer agents – a real privileged scaffold. …

… inhibitor of EGFR, it is currently being developed as an effective anticancer agent [21]. …
inhibitors of Src are being actively investigated as potential anticancer agents [74-76]. Using a …

… of these small molecules as privileged scaffolds with attractive properties and biological
activities for the search of novel anticancer agents. Keywords: Anticancer agents, cancer, fused-…

… of 2-aminothiazole as a privileged scaffold in anti-cancer agents discovery. In addition, …
anti-cancer agents are also probed to offer an insight to design more effective anti-cancer agents …